Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $69.54 USD
Change Today -0.46 / -0.66%
Volume 349.2K
PCRX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - PACIRA PHARMACEUTICALS INC (PCRX)

Pacira Pharmaceuticals, Inc. to Report Q1, 2015 on Apr 30, 2015
CapIQ 04/30/2015 1:00 PM ET
Pacira Pharmaceuticals, Inc. to Report Q4, 2014 on Feb 24, 2015
CapIQ 04/30/2015 1:00 PM ET
Pacira Pharmaceuticals, Inc. to Report Q3, 2014 on Oct 30, 2014
CapIQ 04/30/2015 1:00 PM ET

2013 revenues at Pacira Pharmaceuticals, Inc. totaled $85.6M USD, while annual losses equaled $1.36 per share.

Quarterly Earnings & Estimates - PACIRA PHARMACEUTICALS INC (PCRX)

Actuals vs. Estimates for PACIRA PHARMACEUTICALS INC PCRX

Pacira Pharmaceuticals, Inc.'s Quarterly Earnings

Pacira Pharmaceuticals, Inc. reported 2nd quarter 2014 earnings of $0.04 per share on 08/2/2014.

Annual Earnings & Estimates - PACIRA PHARMACEUTICALS INC (PCRX)

Actuals vs. Estimates for PACIRA PHARMACEUTICALS INC PCRX

Pacira Pharmaceuticals, Inc.'s Annual Earnings

Pacira Pharmaceuticals, Inc. reported annual 2013 losses of $1.36 per share on 02/27/2014.

Quarterly Revenues - PACIRA PHARMACEUTICALS INC (PCRX)

Actuals vs. Estimates for PACIRA PHARMACEUTICALS INC PCRX

Pacira Pharmaceuticals, Inc.'s Quarterly Revenues

Pacira Pharmaceuticals, Inc. had 2nd quarter 2014 revenues of $47.2M USD. This bettered the $42.4M USD consensus of the 7 analysts covering the company. This was 175.2% above the prior year's 2nd quarter results.

Annual Revenues - PACIRA PHARMACEUTICALS INC (PCRX)

Actuals vs. Estimates for PACIRA PHARMACEUTICALS INC PCRX

Pacira Pharmaceuticals, Inc.'s Annual Revenues

Pacira Pharmaceuticals, Inc. had revenues for the full year 2013 of $85.6M USD. This was 118.9% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCRX:US $69.54 USD -0.46

PCRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akorn Inc $43.37 USD +0.05
Alkermes PLC $63.07 USD -1.70
Cumberland Pharmaceuticals Inc $7.13 USD -0.049
Durect Corp $2.26 USD -0.08
Halyard Health Inc $39.27 USD -0.51
View Industry Companies
 

Industry Analysis

PCRX

Industry Average

Valuation PCRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 11.7x
Price/Book 14.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 10.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIRA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.